InfuSystem Holdings, Inc. (NYSE:INFU) Stock Holdings Decreased by Cove Street Capital LLC

Cove Street Capital LLC lessened its stake in InfuSystem Holdings, Inc. (NYSE:INFU) by 12.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 193,450 shares of the company’s stock after selling 28,561 shares during the quarter. InfuSystem makes up approximately 1.9% of Cove Street Capital LLC’s holdings, making the stock its 23rd biggest holding. Cove Street Capital LLC owned about 0.91% of InfuSystem worth $1,633,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of INFU. BNP Paribas Financial Markets raised its stake in InfuSystem by 66.4% during the third quarter. BNP Paribas Financial Markets now owns 4,076 shares of the company’s stock valued at $27,000 after buying an additional 1,626 shares in the last quarter. Legato Capital Management LLC acquired a new stake in shares of InfuSystem during the 4th quarter valued at approximately $85,000. Summit Global Investments bought a new position in InfuSystem during the fourth quarter worth $86,000. Connor Clark & Lunn Investment Management Ltd. acquired a new position in InfuSystem in the third quarter worth $87,000. Finally, Sei Investments Co. bought a new stake in InfuSystem during the fourth quarter valued at $90,000. Institutional investors own 71.13% of the company’s stock.

InfuSystem Stock Performance

INFU stock opened at $5.47 on Friday. InfuSystem Holdings, Inc. has a 1 year low of $5.29 and a 1 year high of $9.97. The stock has a market capitalization of $114.92 million, a price-to-earnings ratio of 91.18 and a beta of 1.75. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.59 and a current ratio of 1.98. The stock’s fifty day moving average is $7.23 and its two-hundred day moving average is $7.53.

Analyst Ratings Changes

Several research analysts have recently commented on INFU shares. Sidoti raised shares of InfuSystem to a “strong-buy” rating in a report on Tuesday, March 18th. StockNews.com raised shares of InfuSystem from a “buy” rating to a “strong-buy” rating in a report on Friday, March 14th.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.